Metsera (MTSR US)

Analysis

Health Care • United States

Clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"